Prof. Dr. Gaia Novarino

Institute of Science and Technology Austria

 Anniversary brochure contribution by Gaia Novarino

Researcher's Profile

Research interests: 

  • Molecular basis of human neuropsychiatric and neurodevelopmental disorders
  • Transporters in brain disorders
  • Human Genetics
  • Stem cell models of human neurological disorders
  • Mouse models of human neurological disorders


Career highlights:

  • From 09/2021 - Vice President for Science and Education, IST Austria
  • Since 2019 – Full Professor at IST Austria, Klosterneuburg, Austria
  • 2016 – Present Vice Chair of FENS-Kavli Network of Excellence
  • 2014 – 2019 Assistant Professor, IST Austria
  • 2010 – 2013 Postdoc Fellow, Joseph Gleeson Lab, UCSD, California, USA
  • 2006 – 2010 Postdoc Fellow, Thomas Jentsch Lab, MDC, Berlin, Germany


Selected Grants and Awards:

  • 2016 Boehringer Ingelheim FENS Research Award 2016
  • 2016 ERC Starting Grant
  • 2016 Simons Foundation Autism Research Initiative (SFARI) Investigator Award
  • 2016 appointment as FENS KAVLI Scholar
  • 2015 – 2018 Partner in the SFB35 – Transmembrane Transporters in Health and Disease
  • DFG Research 2 year fellowship
  • CURE (Citizens United for Research in Epilepsy) young investigator travel award


Ongoing MolTag research projects as supervisor:

  • Lena SCHWARZ: The role of ASD high-risk candidate genes on a cellular and molecular level


Ongoing projects as Co-Supervisor:

  • Mojtaba TAVAKOLI: Expansion microscopy for molecular interrogation of neuronal specimen


Completed projects as supervisor:

  • Jasmin MORANDELL: Illuminating the Role of Cul3 in Autism Spectrum Disorder Pathogenesis, finished 08/2020
  • Dora TARLUNGEANU: Role of the LAT1 transporter in brain development and autism spectrum disorders, finished 02/2018
  • Lisa KNAUS: The role of Slc7a5 in neurodevelopment and neuronal survival; finished 05/2023


Completed projects as co-supervisor:

  • Eva GSCHAIDER-REICHHART: Red light controlled growth factor receptors in all optical drug screening, finished 11/2017
  • Stephanie KAINRATH: Synthetic tools for optogenetic and chemogenetic inhibition of cellular signals, finished 12/2019